Market Research Logo

Global Cardiac Resynchronization Therapy Defibrillator Market 2016-2020

About the Cardiac Resynchronization Therapy Defibrillator (CRT-D) Market

Heart failure, a condition when the heart cannot pump enough blood to meet the body’s need, is one of the leading causes of death. Heart failure and stroke, if occurred together, can lead to major health problems or cause sudden death. Irregularity in ventricular rate can lead to reduction of diastolic dysfunction, a condition when there is abnormality in how the heart fills with blood causing pressure in the pulmonary vessel, leading to AF. Hence, patients with high risk of AF use CRT-D devices to minimize the risk associated with irregular heartbeat. The use of CRT-D devices enhances the functioning of the heart's electrical activity and improves heart rhythm. These devices are small in size and are placed below the collar bone.

Technavio’s analysts forecast the global cardiac resynchronization therapy defibrillator (CRT-D) market to grow at a CAGR of 8.36% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiac resynchronization therapy defibrillator (CRT-D) market for 2016-2020. To calculate the market size, we use revenue generated from the sales of various types of CRT-D devices.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Cardiac Resynchronization Therapy Defibrillator (CRT-D) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • LivaNova
Other prominent vendors
  • BIOTRONIK
  • Cook Medical
  • Spectranetics
Market driver
  • Clinical considerations
  • For a full, detailed list, view our report
Market challenge
  • High cost
  • For a full, detailed list, view our report
Market trend
  • Growing popularity of robotic-assistance surgery
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Cardiac Resynchronization Therapy Defibrillator (CRT-D) Market 2016-2020

Technavio recognizes the following companies as the key players in the global cardiac resynchronization therapy defibrillator (CRT-D) market: Boston Scientific, LivaNova, Medtronic, and St. Jude Medical.

Other Prominent Vendors in the market are: BIOTRONIK, Cook Medical, and Spectranetics.

Commenting on the report, an analyst from Technavio’s team said: “One trend that will boost the market is the growing popularity of robotic-assistance surgery. Robotic surgery is rapidly evolving and also successfully investigated for the implantation of CRT-D in patients. In few instances, the manual implantation of CRT-D may not be possible due to anatomic limitations. The introduction of robotic systems is one of the noteworthy advancements in minimally invasive cardiac surgeries. Robotic technology provides physicians with an excellent view of the operative field and the ability to manoeuvre instruments within close-fitting spaces with precision and control. Robotic surgical procedures help to reduce patients' hospital stays and facilitate better cost management.”

According to the report, a key growth driver is clinical considerations to make a switch to CRT-D technology. The switching from CRT-P to CRT-D, owing to clinical considerations, will propel the market growth. Clinical research studies show that CRT-D devices can reduce re-admissions to hospital for individuals with heart failure. In people with ischaemic cardiomyopathy or ischemic etiology, CRT-D implantation has showed better survival rate than CRT-P devices. There are incremental benefits in CRT-D devices compared to CRT-P devices, as it reduces the risk of sudden cardiac death (SCD) and improves the left ventricular function.

Further, the report states that one challenge that could restrict market growth is the high cost associated with open heart surgeries.



Companies Mentioned

Boston Scientific, LivaNova, Medtronic, St. Jude Medical, BIOTRONIK, Cook Medical, Spectranetics.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Cost analysis of CRT-D device implantation
    • Table Cost comparison of CRT-D and ICD system implantation
    • Table Cost difference of system implantation and medical services in CRT-D 2015
    • Table Cost difference of system implantation and medical services in ICD 2015
    • Table Cost breakdown of system components in CRT-D implantation 2015
    • Table Cost breakdown of system components in ICD implantation 2015
    • Table Cost breakdown of medical services in CRT-D implantation 2015
    • Table Cost breakdown of medical services in ICD implantation 2015
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global CRT-D market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Geographical segmentation
    • Table Global CRT-D market by geography 2015
    • Table Global CRT-D market by geography 2020
    • Table Global CRT-D market by geography 2015-2020 ($ millions)
    • Table Global CRT-D market by geography 2015-2020 (%)
    • CRT-D market in Americas
      • Table CRT-D market in Americas 2015-2020 ($ billions)
    • CRT-D market in EMEA
      • Table Prevalence of AF in few European countries 2014 (%)
      • Table CRT-D market in EMEA 2015-2020 ($ millions)
    • CRT-D market in APAC
      • Table CRT-D market in APAC 2015-2020 ($ millions)
  • Market drivers
    • Increased incidence of cardiac disorders
    • Increasing regulatory approvals
    • Clinical considerations
    • Increased public awareness
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • High cost
    • Popularity of alternative devices
    • Complications associated with CRT-D devices
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Increased use of MRI in clinical applications
    • Focus on R&D
    • Growing popularity of robotic-assistance surgery
  • Vendor landscape
    • Competitive scenario
    • Market share analysis
      • Table Top vendors in global CRT-D market 2015
    • Boston Scientific
      • Table Boston Scientific: Cardiac rhythm management segmentation by revenue 2014
      • Table Boston Scientific: Cardiac rhythm management segmentation by revenue 2013 and 2014 ($ billions)
      • Table Boston Scientific: Cardiac rhythm management geographical segmentation by revenue 2014
      • Table Boston Scientific: Key takeaways
    • LivaNova
      • Table LivaNova: Cardiac rhythm management segmentation by revenue 2014
      • Table LivaNova: Cardiac rhythm management segmentation by revenue 2013 and 2014 ($ millions)
      • Table LivaNova: Key takeaways
    • Medtronic
      • Table Medtronic: Key takeaways
    • St. Jude Medical
      • Table St. Jude Medical: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report